15,000 second chances: Bone Marrow Transplant program celebrates new milestone

April 24, 2019 | Michael Easterling and Samantha Bonar

City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.

Continue Reading

From Oranges, a Powerful Potential Cancer Fighter

June 13, 2019 | Wayne Lewis

Sharad Singhal, Ph.D., research professor in the Department of Medical Oncology and Therapeutics Research, leads investigations focusing on a small molecule that is abundant in the pith of citrus fruit.

Young investigator wins $1 million ORIEN NOVA Grant

June 11, 2019 | Maxine Nunes

The dynamic young founder and director of City of Hope’s Precision Imaging Lab, Ammar Chaudhry, M.D., is one of the first recipients of the new ORIEN NOVA Award. The $1 million grant will fund research for his breakthrough approach to cancer imaging and diagnosis.

Breakthrough drug shows results in lung, colon cancer

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

5 things to know about skin cancer with Christiane Querfeld, M.D., Ph.D.

May 24, 2019 | Kevin Chesley

Skin cancer is a largely survivable and curable form of cancer. Even its most rare and aggressive form, melanoma, has a high cure rate thanks to leading-edge treatments. But it’s still important to be careful, according to City of Hope's Christiane Querfeld, M.D., Ph.D.

Measles outbreak puts cancer patients at risk

May 15, 2019 | Dory Benford

Chemotherapy, immunotherapy and stem cell transplants wipe out patients’ immune systems, leaving them more vulnerable to bacterial and viral infections such as measles.

Colorectal tumor biomarker may predict immunotherapy effectiveness

May 2, 2019 | Zen Vuong

The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.

Exercise Lowers Heart Disease Risk in Breast Cancer Patients

April 23, 2019 | Letisia Marquez

After taking part in a 16-week exercise intervention, women who had early-stage breast cancer, and who were also inactive and overweight or obese, had a lower risk of developing cardiovascular disease, according to a new study in JAMA Oncology.